XHKG
0383
Market cap133mUSD
Jul 17, Last price
0.97HKD
1D
-11.82%
Jan 2017
-87.56%
Name
China Medical & HealthCare Group Ltd
Chart & Performance
Profile
China Medical & HealthCare Group Limited, an investment holding company, primarily operates hospitals in the People's Republic of China, Australia, and the Philippines. It operates through six segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. The company is also involved in the property development of independent living units; and project management of health campus with a focus on elderly care and retirement community comprising elderly nursing homes, service apartments, and independent living units, as well as a shopping mall, retail shops, and club hall facilities. In addition, it develops and sells properties and land; leases residential and office properties; and provides money lending and healthcare services. Further, the company is involved in trading of medical equipment and related supplies; and securities listed in overseas exchange. The company was formerly known as COL Capital Limited and changed its name to China Medical & HealthCare Group Limited in February 2016. China Medical & HealthCare Group Limited was incorporated in 1990 and is headquartered in Wanchai, Hong Kong.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
Income | ||||||||||
Revenues | 1,627,199 3.72% | 1,568,824 9.03% | 1,438,865 -2.55% | |||||||
Cost of revenue | 1,533,199 | 1,519,362 | 1,536,250 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 94,000 | 49,462 | (97,385) | |||||||
NOPBT Margin | 5.78% | 3.15% | ||||||||
Operating Taxes | 15,028 | 14,912 | 1,976 | |||||||
Tax Rate | 15.99% | 30.15% | ||||||||
NOPAT | 78,972 | 34,550 | (99,361) | |||||||
Net income | 28,773 154.74% | 11,295 -109.14% | (123,574) -9.99% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 309,292 | |||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 392,360 | 315,950 | 550,795 | |||||||
Long-term debt | 446,673 | 521,264 | 428,226 | |||||||
Deferred revenue | 8,104 | 51,020 | ||||||||
Other long-term liabilities | 34,504 | (122,786) | ||||||||
Net debt | (48,546) | (55,203) | 352,047 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 356,080 | 15,384 | ||||||||
CAPEX | (198,046) | (137,967) | ||||||||
Cash from investing activities | (178,826) | (134,338) | ||||||||
Cash from financing activities | 100,573 | 88,919 | ||||||||
FCF | 159,288 | (612,719) | (192,614) | |||||||
Balance | ||||||||||
Cash | 885,428 | 890,528 | 614,083 | |||||||
Long term investments | 2,151 | 1,889 | 12,891 | |||||||
Excess cash | 806,219 | 813,976 | 555,031 | |||||||
Stockholders' equity | 1,895,698 | (381,251) | (1,042,515) | |||||||
Invested Capital | 1,959,322 | 3,098,330 | 3,511,821 | |||||||
ROIC | 3.12% | 1.05% | ||||||||
ROCE | 3.40% | 1.77% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 1,086,001 | 923,826 | 732,048 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 94,000 | 147,680 | 7,308 | |||||||
EV/EBITDA | ||||||||||
Interest | 47,807 | 59,015 | ||||||||
Interest/NOPBT | 96.65% |